Download PDF
Am J Perinatol 2019; 36(12): 1264-1270
DOI: 10.1055/s-0038-1676614
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Evolution of the Bacillus Calmette–Guerin Scar and Its Association with Birth and Pregnancy Characteristics in a Prospective Cohort of Infants in Iquitos, Peru

Francesca Schiaffino
1   Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
2   Faculty of Science and Philosophy, Universidad Peruana Cayetano Heredia, Lima, Peru
,
Gwenyth O. Lee
3   Department of Global Community Health and Behavioral Sciences, Tulane University School of Public Health and Tropical Medicine, New Orleans, Louisiana
4   Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, Michigan
,
Maribel Paredes-Olortegui
5   Research and Development Area, Asociación Benéfica Prisma, Iquitos, Lima, Peru
,
Lilia Cabrera
5   Research and Development Area, Asociación Benéfica Prisma, Iquitos, Lima, Peru
,
Pablo Penataro-Yori
1   Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
5   Research and Development Area, Asociación Benéfica Prisma, Iquitos, Lima, Peru
,
Robert H. Gilman
1   Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
2   Faculty of Science and Philosophy, Universidad Peruana Cayetano Heredia, Lima, Peru
5   Research and Development Area, Asociación Benéfica Prisma, Iquitos, Lima, Peru
,
Margaret N. Kosek
1   Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
5   Research and Development Area, Asociación Benéfica Prisma, Iquitos, Lima, Peru
› Author Affiliations Funding This work was supported by the National Institutes of Health (NIH) 5D43TW009349–03 “Inter-American Training for Innovations in Emerging Infectious Diseases” (to GOL). F. S. was supported by FONDECYT-CONCYTEC (grant contract number 246–2015-FONDECYT), and the UJMT Fogarty Global Health Fellows Consortium comprising Johns Hopkins University, the University of North Carolina, Morehouse University, and Tulane University (NIH Research Training Grant # D43 TW009340 funded by the NIH Fogarty International Center, NINDS, NIMH, NHBLI and NIEHS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Further Information

Publication History

21 August 2018

03 November 2018

Publication Date:
24 December 2018 (online)

    Permissions and Reprints

Abstract

Background Bacillus Calmette–Guerin (BCG) scar formation is considered a visual marker of vaccination and cell-mediated immune response. This study characterized the association between pregnancy and birth characteristics with BCG scar formation.

Study Design Pregnant women were enrolled prospectively. Infants were followed up for the first 6 months of life, and the diameter of the BCG scar was recorded. Marginal models were fitted to assess the association of BCG scar diameter with pregnancy and birth characteristics using linear regressions with generalized estimating equations.

Results A total of 307 infants were enrolled, of whom 19.2% (59/307) were of low birth weight. Among those with known gestational age, 7.1% were preterm births (21/295). Overall, 98.7% (303/307) of infants developed a BCG scar. BCG scar trends in a tropical environment, such as the Amazon, differ from the trends evidenced in the capital of Peru. For every additional week of gestational age, the mean scar diameter increased by 0.1 mm (95% confidence interval [CI]: 0.02, 0.24; p = 0.017). Maternal illness during pregnancy impacted BCG scar size, as the infants of mothers who self-report fever had a smaller scar diameter (1 mm, 95% CI: 0.5, 1.8 mm; p = 0.001).

Conclusion The immune reaction to the BCG vaccination is affected by gestational age at birth and systemic inflammatory episodes during pregnancy.

Keywords

Bacillus Calmette–Guerin - preterm births - tuberculosis - Peru

Note

The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.


Authors' Contributions

F.S. and G.O.L. contributed to data analysis and manuscript elaboration, M.P.O. and L.C. contributed to study design and data collection, and P.P.Y., R.H.G., and M.N.K. contributed to study design, data analysis, and manuscript elaboration.


 

  • References

  • 1 World Health Organization. Global tuberculosis report 2015, 20th ed. World Health Organization
    PubMed
  • 2 WHO/UNICEF coverage estimates 2012 revision. July 2013 Immunization Vaccines and Biologicals, (IVB), World Health Organization
    PubMed
  • 3 Peru. Encuesta Demografica y de Salud Familiar. ENDES Continua 2004–2006. Instituto Nacional de Estadistica y Demografia (INEI). Direccion Tecnica de Demografia e Indicadores Sociales. Direccion Nacional de Censos y Encuestas. 2007
    PubMedGoogle Scholar
  • 4 Hanekom WA. The immune response to BCG vaccination of newborns. Ann N Y Acad Sci 2005; 1062: 69-78
    CrossrefPubMedGoogle Scholar
  • 5 Garly ML, Martins CL, Balé C. , et al. BCG scar and positive tuberculin reaction associated with reduced child mortality in West Africa. A non-specific beneficial effect of BCG?. Vaccine 2003; 21 (21-22): 2782-2790
    CrossrefPubMedGoogle Scholar
  • 6 Mawa PA, Webb EL, Filali-Mouhim A. , et al. Maternal BCG scar is associated with increased infant proinflammatory immune responses. Vaccine 2017; 35 (02) 273-282
    CrossrefPubMedGoogle Scholar
  • 7 Floyd S, Ponnighaus JM, Bliss L. , et al. BCG scars in northern Malawi: sensitivity and repeatability of scar reading, and factors affecting scar size. Int J Tuberc Lung Dis 2000; 4 (12) 1133-1142
    PubMedGoogle Scholar
  • 8 Timmermann CA, Biering-Sørensen S, Aaby P. , et al. Tuberculin reaction and BCG scar: association with infant mortality. Trop Med Int Health 2015; 20 (12) 1733-1744
    CrossrefPubMedGoogle Scholar
  • 9 Storgaard L, Rodrigues A, Martins C. , et al. Development of BCG scar and subsequent morbidity and mortality in rural Guinea-Bissau. Clin Infect Dis 2015; 61 (06) 950-959
    CrossrefPubMedGoogle Scholar
  • 10 Roth A, Gustafson P, Nhaga A. , et al. BCG vaccination scar associated with better childhood survival in Guinea-Bissau. Int J Epidemiol 2005; 34 (03) 540-547
    CrossrefPubMedGoogle Scholar
  • 11 Nissen TN, Birk NM, Smits G. , et al; Calmette Study Group. Bacille Calmette-Guérin (BCG) vaccination at birth and antibody responses to childhood vaccines. A randomised clinical trial. Vaccine 2017; 35 (16) 2084-2091
    CrossrefPubMedGoogle Scholar
  • 12 Ferreira AA, Bunn-Moreno MM, Sant'Anna CC, Ferreira MFC. BCG vaccination in low birth weight newborns: analysis of lymphocyte proliferation, IL-2 generation and intradermal reaction to PPD. Tuber Lung Dis 1996; 77 (05) 476-481
    CrossrefPubMedGoogle Scholar
  • 13 Kaur S, Faridi MMA, Agarwal KN. BCG vaccination reaction in low birth weight infants. Indian J Med Res 2002; 116: 64-69
    PubMedGoogle Scholar
  • 14 Negrete-Esqueda L, Vargas-Origel A. Response to Bacillus Calmette-Guérin vaccine in full-term and preterm infants. Am J Perinatol 2007; 24 (03) 183-189
    Article in Thieme ConnectPubMedGoogle Scholar
  • 15 Santiago EM, Lawson E, Gillenwater K. , et al. A prospective study of bacillus Calmette-Guérin scar formation and tuberculin skin test reactivity in infants in Lima, Peru. Pediatrics 2003; 112 (04) e298-e302
    CrossrefPubMedGoogle Scholar
  • 16 Analisis de la situacion de salud de la region Loreto. Año 2010. Direccion Ejecuvita del Centro de Prevencion y Control de Enfermedades. Direccion de Epidemiologia. Iquitos, Loreto
    PubMedGoogle Scholar
  • 17 Ballard JL, Khoury JC, Wedig K, Wang L, Eilers-Walsman BL, Lipp R. New Ballard Score, expanded to include extremely premature infants. J Pediatr 1991; 119 (03) 417-423
    CrossrefPubMedGoogle Scholar
  • 18 Frankel H, Byberg S, Bjerregaard-Andersen M. , et al. Different effects of BCG strains - a natural experiment evaluating the impact of the Danish and the Russian BCG strains on morbidity and scar formation in Guinea-Bissau. Vaccine 2016; 34 (38) 4586-4593
    CrossrefPubMedGoogle Scholar
  • 19 Sivarajah N, Sivayogan S, Jegatheesan J, Gnananathan V. BCG vaccination and development of a scar. Ceylon Med J 1990; 35 (02) 75-77
    PubMedGoogle Scholar
  • 20 Dhanawade SS, Kumbhar SG, Gore AD, Patil VN. Scar formation and tuberculin conversion following BCG vaccination in infants: a prospective cohort study. J Family Med Prim Care 2015; 4 (03) 384-387
    CrossrefPubMedGoogle Scholar
  • 21 Yori PP, Lee G, Olórtegui MP. , et al. Santa Clara de Nanay: the MAL-ED cohort in Peru. Clin Infect Dis 2014; 59 (Suppl. 04) S310-S316
    CrossrefPubMedGoogle Scholar
  • 22 Lee G, Yori P, Olortegui MP. , et al. Comparative effects of vivax malaria, fever and diarrhoea on child growth. Int J Epidemiol 2012; 41 (02) 531-539
    CrossrefPubMedGoogle Scholar
  • 23 Elliott AM, Mawa PA, Webb EL. , et al. Effects of maternal and infant co-infections, and of maternal immunisation, on the infant response to BCG and tetanus immunisation. Vaccine 2010; 29 (02) 247-255
    CrossrefPubMedGoogle Scholar
  • 24 Malhotra I, Mungai P, Wamachi A. , et al. Helminth- and Bacillus Calmette-Guérin-induced immunity in children sensitized in utero to filariasis and schistosomiasis. J Immunol 1999; 162 (11) 6843-6848
    PubMedGoogle Scholar
  • 25 Roth A, Sodemann M, Jensen H. , et al. Tuberculin reaction, BCG scar, and lower female mortality. Epidemiology 2006; 17 (05) 562-568
    CrossrefPubMedGoogle Scholar
  • 26 Barreto ML, Rodrigues LC, Silva RCR. , et al. Lower hookworm incidence, prevalence, and intensity of infection in children with a Bacillus Calmette-Guérin vaccination scar. J Infect Dis 2000; 182 (06) 1800-1803
    CrossrefPubMedGoogle Scholar
  • 27 Pérez-Then E, Shor-Posner G, Crandall L, Wilkinson J. The relationship between nutritional and sociodemographic factors and the likelihood of children in the Dominican Republic having a BCG scar. Rev Panam Salud Publica 2007; 21 (06) 365-372
    PubMedGoogle Scholar